Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nodularis Prurigo”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableUnknownNCT04681300
What this trial is testing

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Who this might be right for
Prurigo NodularisAtopic Dermatitis
Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Ended earlyNCT06527404
What this trial is testing

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Amgen 469
Large-scale testing (Phase 3)Study completedNCT03546816
What this trial is testing

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Who this might be right for
PruritusPrurigo Nodularis
Vyne Therapeutics Inc. 285
Not applicableLooking for participantsNCT07276425
What this trial is testing

Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
UMC Utrecht 40
Large-scale testing (Phase 3)Study completedNCT05755438
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo
Incyte Corporation 204
Not applicableStudy completedNCT06427122
What this trial is testing

Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

Who this might be right for
Atopic DermatitisPrurigo Nodularis
Tamar Nijsten 96
Testing effectiveness (Phase 2)Study completedNCT00869089
What this trial is testing

Safety and Efficacy of CC-10004 for Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
University Hospitals Cleveland Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT05038982
What this trial is testing

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Who this might be right for
Prurigo NodularisPruritusChronic Pruritus+2 more
Johns Hopkins University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04204616
What this trial is testing

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 500
Large-scale testing (Phase 3)Looking for participantsNCT06779136
What this trial is testing

Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Shanghai Mabgeek Biotech.Co.Ltd 160
Large-scale testing (Phase 3)Study completedNCT04202679
What this trial is testing

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

Who this might be right for
Neurodermatitis
Sanofi 160
Large-scale testing (Phase 3)Study completedNCT04183335
What this trial is testing

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)

Who this might be right for
Neurodermatitis
Sanofi 151
Large-scale testing (Phase 3)Study completedNCT04501666
What this trial is testing

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 286
Not applicableUnknownNCT01870050
What this trial is testing

Dapsone Prurigo Study

Who this might be right for
Lichen Simples Chronicus and Prurigo
Cook County Health 20
Not applicableUnknownNCT00532519
What this trial is testing

Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Hadassah Medical Organization
Large-scale testing (Phase 3)Study completedNCT05052983
What this trial is testing

Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Galderma R&D 34
Testing effectiveness (Phase 2)Study completedNCT02196324
What this trial is testing

Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Vyne Therapeutics Inc. 128
Large-scale testing (Phase 3)Ended earlyNCT03540160
What this trial is testing

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Who this might be right for
PruritusPrurigo NodularisAtopic Dermatitis+1 more
Vyne Therapeutics Inc. 558
Large-scale testing (Phase 3)Study completedNCT04501679
What this trial is testing

Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 274
Not applicableLooking for participantsNCT06988618
What this trial is testing

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Who this might be right for
Prurigo Nodularis
Galderma R&D 600
Next Page